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Dominant T cells in idiopathic nephrotic syndrome of child- less frequently focal global sclerosis (FGS) may be seen
hood. [2]. Therapy of INS was well elaborated in several clinical
Background. Because of several studies, idiopathic ne- studies and mainly consists of steroids. In case of fre-phrotic syndrome (INS) of childhood is suspected to have an
quent relapsing INS, additional immunosuppression withimmunologic pathogenesis with T cells playing a major role.
cyclophosphamide or cyclosporine A has been approvedTo investigate this hypothesis further, we studied the diversity
of the CDR3 region of the T-cell receptor (TCR) b-chain from [3–5].
peripheral T cells isolated from patients with INS. An association of INS with certain human leukocyte
Methods. The study was performed over a three-year period antigens (HLA) has been repeatedly reported. Theto obtain longitudinal data on the repertoire of peripheral T
HLA-B8-DR3 haplotype, -DR7 and -DQ2 are signifi-cells. mRNA from peripheral mononuclear cells (PBMCs) of
cantly associated with disease susceptibility [6–10]. Inseven INS patients and two healthy controls (NHD) was pre-
pared and analyzed for CDR3 length polymorphism of TCR 1974, Shalhoub suggested INS to be a disorder of T-cell
b-chain by spectratyping. function [11]. Since then, a number of studies have shown
Results. All INS patients presented individually skewed
immunologic abnormalities in this disease. Activatedspectratype histograms in at least one Vb-family. Patients suf-
CD4-positive (CD41) T cells were found to be up-regu-fering from a frequent relapsing course of INS or a focal global
sclerosis showed some alterations to persist in all samples iso- lated during active stages of disease, producing increased
lated in the observation period (up to 3 years). In addition, levels of interleukin-2 (IL-2) [12, 13]. Moreover, the
sequence analyses of the b-chain of the TCR CDR3 region CD41/CD81 ratio was observed to be inversed, point-
confirmed clonal expansion of peripheral T cells in those pa-
ing to an increased cytotoxic T-cell recruitment duringtients who had displayed spectratype alterations.
active stages of disease [14].Conclusions. The data give strong evidence for an direct
involvement of CD81 T cells in the complicated course of Human leukocyte antigen molecules, the presented
INS. antigenic peptide and the T-cell receptor (TCR) build a
trimer complex essential for T-cell activation. Consider-
ing the HLA association of INS and the published T-cell
Idiopathic nephrotic syndrome (INS) of childhood, abnormalities, one may expect specific T-cell activation
the most frequent glomerular disease of children, is char- leading to clonally expanded T-cell populations. Molecu-
acterized by proteinuria (.1 g/m2/day), hypoalbumi- lar analyses on the basis of the TCR RNA have been
nemia (,2.5 g/dL) and edema. INS is mostly combined shown to be powerful tools for the investigation of the
with minimal change nephrotic syndrome (MCNS), char- T-cell repertoire [15–18]. The TCR b-chain is rearranged
acterized with foot process fusion on electron microscopy during T-cell development by recombination of various
and no deposits found in immunofluorescence micros- V, D, and J gene segments and not germ-line–derived
copy [1]. In some cases, diffuse mesangial proliferation interponating nucleotides together building up the
or focal and segmental glomerular sclerosis (FSGS) or CDR3 region. The CDR3 region of the TCR b-chain is
essential for the peptide recognition [19]. Deviations
from the normal CDR3 length distribution reflect se-Key words: childhood nephrotic syndrome, CDR3 length polymor-
phism, T cell receptor, immune system, focal global sclerosis. lected expansions of the corresponding T cells. These
deviations reflecting clonal T-cell expansions may be de-Received for publication February 24, 1999
tected with spectratyping a high-resolution analysis ofand in revised form September 2, 1999
Accepted for publication September 9, 1999 the CDR3 length polymorphism [20, 21]. The aim of our
longitudinal study was to characterize T-cell activationÓ 2000 by the International Society of Nephrology
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through analyses of TCR b-chain polymorphism in order The purity of the CD41 T-cell fractions was higher than
97%. Hence, the CD4 fraction included less than 3%to define T-cell candidates involved in etiopathogenesis
of INS. CD41 T cells.
RNA and cDNA synthesis
METHODS
Total RNA was purified by the Trizol technique ac-
Patients and controls cording to the manufacturer’s instruction (GIBCO, Eg-
genstein, Germany). Briefly 2 3 106 PBMCs were pel-The study included seven patients suffering from INS
deriving from the Department of Nephrology in the Chil- leted and lyzed in 1 mL Trizol and 0.2 mL chloroform
(HCCl3). After centrifugation, the aqueous phase wasdren’s Hospital of Erlangen, as well as two healthy volun-
teers. All participants of the study, including their par- collected, precipitated with isopropanol, and resus-
pended in RNase-free water. The cDNA synthesis wasents, have been informed about the purpose of the study.
The study was approved by the ethics committee of the performed using M-MuLV reverse transcriptase and ran-
dom primers (Stratagene, Heidelberg, Germany).University of Erlangen-Nuremberg. Six INS patients
were steroid sensitive, and one patient showed steroid
Polymerase chain reaction amplification of cDNAplus cyclosporine dependency and a histology of FGS.
Three of the patients had a frequent relapsing course Polymerase chain reaction (PCR) was performed in
10 mL volume with 120 mmol/L dNTPs each, 3 mmol/Ldefined as more than four relapses a year [22]. Two
showed an infrequent relapsing course, whereas the pa- MgCl2, 0.5 mmol/L primer each, and 0.8 U Taq using a
hot air rapid cycler (Idaho Technology, Ames, ID, USA).tient with FGS showed persistent disease activity. Four
of the patients underwent renal biopsy showing MCNS PCR conditions were as follows: 35 cycles, denaturation
at 948C for one second, annealing at 558C for one second,in three cases and FGS in one case. The patients received
different drug regiments during their course of disease and elongation at 728C for 20 seconds.
Polymerase chain reaction amplification was per-as indicated in Figure 1. Most of the patients have been
analyzed for Epstein-Barr virus (EBV) infections, as this formed using a panel of 22 oligonucleotides specific for
Vb families published by Choi et al as upstream primermight cause relevant changes in the T-cell repertoire
[23]. HLA-DRB1 typing has been performed with poly- [18]. A 59-HEX (6-carboxy-29,49,79,4,7-hexachloroflu-
orescein)-labeled oligonucleotide (59-HEX-CTC TGCmerase chain reaction-sequence-specific oligo (PCR-SSO)
typing using locus-specific primers and allele-specific TTC TGA TGG CTC AAA CAC-39) served as down-
stream primer. The PCR products were run on 2% aga-oligonucleotides [24]. Figure 1 shows detailed informa-
tion on EBV serology and HLA-DRB1 typing. The study rose gels, stained with ethidium bromide, and visualized
under ultraviolet light.included repeated analyses of peripheral mononuclear
cells (PBMCs) within a four-month period for normal
CDR3 spectratypinghealthy blood donor RA (NHD) up to a 43-month period
for patient DC. One microliter of fluorescent PCR product was redis-
solved in 3 mL formamide (CH3NO), heat denatured at
Cell preparation 958C for two minutes, chilled, loaded on a prewarmed
5% polyacrylamid (PAA) sequencing gel, and run on anPeripheral mononuclear cells were isolated from
whole blood by Lymphoprep (Nycomed Pharma AS, automated DNA sequencer type 373 at 30 W of constant
power for six hours using Genescan Software (ABI,Oslo, Norway) density gradient centrifugation.
Subsequently, CD41 and CD4-T cells were separated Weiterstadt, Germany).
by high-gradient magnetic sorting using the Vario-
Evaluation of the spectratype histogramsMACSE technique (Miltenyi Biotec GmbH, Bergisch-
Gladbach, Germany). PBMCs were incubated with satu- The evaluation of spectratyping data was done as de-
scribed elsewhere. Briefly, a standard was establishedrating concentrations of CD4 monoclonal antibody
(mAb) conjugated with paramagnetic microbeads for 15 using 25 NHD histograms, standardized by setting the
central peak as 100%. For individual histograms, devia-minutes on ice, were washed in phosphate-buffered sa-
line (PBS) supplemented with 0.5% bovine serum albu- tion (D) and the amplitude (A) were estimated, and the
relative deviation (DR) was calculated DR 5 D/A. Detailsmin (BSA) and 5 mmol/L ethylenediaminetetraacetic
acid (EDTA), and were separated according to the man- on the evaluation of spectratyping data are published
elsewhere [16].ufacturer’s instructions. To evaluate the efficiency of the
cell separation, aliquots of the positively enriched and
Cloning and sequencing of TCR b transcriptsnegatively depleted cell fractions were stained with di-
rectly conjugated CD4 and CD8 mAb (PharMingen, San T-cell receptor b-chain PCR products were cloned
with the pCR2.1 vector system (Invitrogen, NV Leek,Diego, CA, USA) and were analyzed by flow cytometry.
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Fig. 1. Overview of CDR3 analyses of TCR b-chains from peripheral T cells and clinical data of idiopathic nephrotic syndrome (INS) patients
and controls. The year of birth is indicated in parentheses. The HLA-DR typing and the EBV status are given in column 1. Abbreviations are:
AD, active disease; C, cyclosporine A; E, endoxan; F, FK506; FR, frequent relapsing; FSGS, focal segmental glomerulus sclerosis; IM, initial
manifestation; IR, infrequent relapsing; K, control; M, methotrexate; MCNS, minimal change nephrotic syndrome; N, no drugs; NB, no biopsy;
NHD, normal healthy donor; P, patient; RM, remission; S, steroids; SD, steroid dependent; SS, steroid sensitive. Symbols are: (j) T-cell expansions
found by CDR3 spectratyping; (s) cloned and sequenced CDR3 fragments.
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Fig. 2. T cell receptor (TCR) b-chain CDR3 spectratype histograms from 20 Vb gene families of peripheral T cells isolated from patient P1 at
three time points. Upper panel, 0 months; intermediate panel, 32 months; and lower panel, 37 months. Time points refer to data presented in
Figure 1.
The Netherlands). Sequencing was performed using ABI in complexity during the course of the disease. This re-
sults in more and more Vb families showing deviationsPRISM Ready Reaction DyeDeoxy Terminator Cycle
Sequencing and an ABI PRISM 373 DNA Sequencer in CDR3-length polymorphisms apart from a normal
distribution. Interestingly, a pair of homozygotic twins(ABI). The identities of TCR sequences obtained were
established by comparison with published sequences (P51 and P42) was found to have an individual peak
pattern in each twin.(GenBank R81.0).
The most extraordinary changes were found in patient
P14, who was suffering from an INS with FGS. Within
RESULTS fours months of the disease, most of the Vb families
CDR3 spectratyping showed altered patterns in spectratyping.
Spectratyping of the CDR3-length polymorphism
CDR3 spectratyping in T-cell subsetsshowed distinct differences when comparing patients and
Spectratyping of the CDR3 length polymorphism washealthy controls (Fig. 1). Moreover, a comparison of
additionally performed in T cells after separation intopatients with different courses of INS results in charac-
the CD41 and CD4 fraction by high-gradient magneticteristic patterns. Each patient had individual peaks,
sorting using the VarioMACSE technique. With onewhereas predominant CDR3 lengths have not been ob-
exception, peaks were found to be located in the CD4-served in healthy controls. In the patients with an infre-
depleted fraction of T cells. Figure 4 shows examplesquent relapsing course of INS, the longitudinal persis-
from two patients after PBMCs have been separated fortence of CDR3 peaks was present just in one case.
CD41 and CD4-T cells. Obviously, CDR3 spectratypingMoreover, all patients in this group showed alterations in
is able to distinguish dominant TCR b-chain lengths intheir T-cell repertoire in only one Vb family. In contrast,
both fractions.patients suffering from a frequent relapsing course of
INS showed more complicated patterns of CDR3 diver-
Sequencing the CDR3 regionsity. They had alterations in more than one Vb family
indicated through peaks in the corresponding Vb spec- A total number of 600 PCR products has been cloned
and sequenced from 23 preparations indicated with a dottratypings. Figure 2 gives an example for the longitudinal
course of one patient (P1) showing spectratyping data in Figure 1. The number of analyzed CDR3 sequences
ranged from a minimum of 6 up to 51 products clonedfrom the first manifestation of the disease (month 0) and
two follow-up analyses (months 32 and 37). The patterns and sequenced from one reverse transcription-PCR (RT-
PCR). For a better comparison, we focused on two majordiffer according to some families (for example, Vb 11),
whereas other peaks tend to persist during the entire questions: a longitudinal follow-up of Vb9 in four pa-
tients and one healthy control, and a longitudinal analysisobservation period. Figure 3 shows the persisting Vb6
peak of the same patient, which has been found in all of Vb16 sequences in one patient (P1) for a 43-month
period (see Figure 3). Clusters of identical sequencesspectratyping analyses performed thus far. Moreover,
patients with a frequent relapsing course of the disease were defined to include more than two identical se-
quences in one sample and/or more than two identicalhad patterns in CDR3 spectratyping that tend to increase
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Fig. 3. TCR b-chain CDR3 spectratype histograms (Vb 16) of peripheral T cells isolated from patient P1 at eight time points over a three years
period. Time points refer to data presented in Figure 1. The clonally expanded T cells are shown to persist for the entire observation period with
the strongest skewing at 12 month during a course of active disease.
Fig. 4. Comparison of TCR b-chain CDR3 spectratype histograms of isolated CD4-positive and CD4-negative T cells isolated from peripheral
blood of frequently relapsing INS patient (P51 and P42). Upper panel, patient P51 (3 months; Oct. 96); lower panel, patient P42 (4 months;
Oct. 96).
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Table 1. Amino acid sequences and frequency of the CDR3 region of clonally expanded TCR b-chains in patient P1a
Junctional regions Frequency
Patient
P1(Vb) Vb NDbN Jb 0 months 8 months 12 months 32 months 37 months
Vb2 CSA AGTG NEKLFFGSGTQLSVL (1.4) 4/40
CSA TSVDSYY TDTQYFGPGTRLTVL (2.3) 5/40
Vb3 CSVE VWDSS YNEQFFGPGTRLTVL (2.1) 8/46
Vb4 CASS HKTASTGH GELFFGEGSRLTVL (2.2) 3/38
Vb6 CASSL SS YNEQFFGPGTRLTVL (2.1) 4/51
Vb16 CASSQ DRD NEQFFGPGTRLTVL (2.1) 1/6 2/17 1/6 10/51 5/31
a Patient with frequent relapsing idiopathic nephrotic syndrome
Table 2. Amino acid sequences and frequency of the CDR3 region of clonally expanded TCR b-chains in patients
with idiopathic nephrotic syndrome
Junctional regions Frequency
Patient (Vb) Vb NDbN Jb 0 months 8 months 12 months 32 months 37 months
P1 (Vb16) CASSQ DRD NEQFFGPGTRLTVL (2.1) 1/6 2/17 1/6 10/51 5/31
0 months 11 months
P2 (Vb9) CASS PWTAY NEQFFGPGTRLTVL (2.1) 6/23 5/16
CASS PRWGLAKTY NEQFFGPGTRLTVL (2.1) 1/23 1/16
0 months 3 months
P51 (Vb9) CASS PRQGVD EQYFGPGTRLTVT (2.7) 4/21 5/14a 0/22b
a Isolated CD4 negative T cells were analyzed
b Isolated CD4 positive T cells (97% pure) were analyzed
sequences in the longitudinal follow-up of a single pa- of INS showed only temporary expansions of T cells.
tient. Comparing the sequences between different indi- Interestingly, the patient with a steroid-dependent INS
viduals, we could not interindividually detect identical (see P14 in Fig. 1) presenting with FGS on histology
sequences. Vb families without any evidence for a domi- was found to have alterations, indicating restricted TCR
nant T-cell clone showed no identical sequences compar- diversity in most Vb families. As this patient finally re-
ing different preparations in patients as well as in con- ceived treatment with FK 506, an agent known for its
trols. Individual persistence of identical sequences in cytotoxic effect to T cells, the huge patterns found in
the longitudinal course could only be observed in the this case might be a result of drug therapy. Healthy
patient’s group. Repeated sequences indicating per- controls were not found to have skewed patterns of spec-
sisting dominant T cells could only be analyzed if skewed tratyping nor repeated sequences at any time of investi-
patterns of the corresponding CDR3 region have been gation. When analyzing the TCR b-chain sequences for
found in spectratyping. In patient P1, the dominant Vb16 identical sequences, on one hand, identical sequences
clone could be detected in all samples analyzed so far could indicate oligoclonal T-cell expansions because a
spanning a 43-month period with spectratypings and 37 clone would result in a higher proportion of T cells bear-
months with sequencing, respectively (Tables 1 and 2). ing identical TCR. On the other hand, the methods used
Comparing the sequences of different patients, the Jb in the study include PCR, which might cause a bias on
2.1 element was found to be the most frequent J element. the frequency of certain sequences. Analyzing our data,
Interindividual comparisons of the V-D-J b junctional identical sequences could only be found if the corre-
regions did not reveal a common sequence motif. sponding Vb family had a dominant peak in the spec-
tratyping of the CDR3 region, respectively. The longitu-
DISCUSSION dinal persistence of identical sequences could only be
observed in Vb families with altered spectratyping pat-The data on the length polymorphism of the TCR b
terns as well. Both observations support our hypothesisCDR3 region in INS patients indicate patients suffering
that identical sequences result from oligoclonal T-cellfrom complicated courses of the disease to have persis-
expansions. No obvious sequence motif was found com-tent expansions of T cells. Each patient seems to develop
paring the junctional regions of different patients withan individual pattern of T-cell predominance. With one
repeated sequences during the longitudinal study. As theexception, this phenomenon is limited to the CD81 frac-
tion of T cells. Patients with infrequent relapsing courses CDR3 region is essential for peptide recognition [19],
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one would not expect a single peptide to be the target open as to how these T cells interact with the basal
of those T cells. Limited TCR usage and oligoclonal membrane to cause proteinuria. A “nephrotic factor”
T-cell expansion of CD81 cells have been described in proposed by the literature and not well defined so far
several autoimmune diseases such as rheumatoid arthri- might be a product of dominant T cells [33, 34].
tis [25], lupus erythematosus [16], or experimental auto- Apart from pathogenesis, our data on predominant T
immune encephalomyelitis [26]. Moreover, oligoclonal cells in frequently relapsing INS might be of relevance
expansion of CD81 cells has been observed in viral to therapy. Early treatment with alkylating agents such
infections with HTLV-I [27], measles [28], persistent as cyclophosphamide or chlorambucil has been shown
EBV infection [23], and others. The data obtained from to modify the course in patients with a frequent relapsing
CDR3 analyses led us to propose INS to be driven by INS [5]. Thus, further investigations are needed to clarify
an autoimmune process or a chronic infection. In that whether or not analyses of the TCR repertoire are a
context, persistent oligoclonal expansion of CD81 cells predictive factor for the prognosis of INS.
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